The global oscillating positive expiratory pressure (opep) devices market was estimated to be worth US$ 128.8 million in 2021 and is anticipated to increase to US$ 195.2 million by 2029, increasing at a CAGR of 5.3% over the forecast period.
According to the study, the global market for OPEP devices is anticipated to develop significantly over the course of the forecast period due to a number of factors, including an increase in the availability of these devices on a regional level. The manufacturer-led innovation in device design and the rising use of OPEP devices among patients with respiratory disorders are credited with the growth prospects.
Equip Yourself With The Tools For Progress And Prosperity – Get Our Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-3397
Regions such as North America and Europe are expected to hold a prominent market share in terms of value. However, the East Asia market is expected to project lucrative growth in the global oscillating positive expiratory pressure devices market in the forecast period of 2019-2029. This growth is majorly propelled by increasing regional manufacturers resulting in increased product availability at affordable costs.
Furthermore, prevalence of chronic obstructive pulmonary diseases (COPD) is on the rise due to increasing smoking population in China and aging population in Japan with respiratory disorders. Although, low awareness about oscillating positive expiratory pressure devices among healthcare professionals and patients is hampering the potential growth of the oscillating positive expiratory pressure devices market.
Mouthpiece OPEP Devices – Preferred Choice for Airway Clearance:
Based on the analysis of OPEP devices market by product, mouthpiece oscillating positive expiratory pressure devices are expected to hold a prominent value share in the global market. This, according to FMI’s analysis, has majorly resulted from the ease of use of these devices as well as comparatively wider availability in the market.
On the other side, based on indication, the COPD is likely to consume a majority share of the oscillating positive expiratory pressure devices market value. This is majorly due to the higher prevalence of the disease and adoption of oscillating positive expiratory pressure devices for disease management. Although, cystic fibrosis is rare disease and has limited patient pool yet adoption of oscillating positive expiratory pressure devices remains highest in cystic fibrosis patients.
Our Analyst Is Available To Help You With Any Inquiries You May Have! https://www.futuremarketinsights.com/ask-question/rep-gb-3397
OPEP Devices Market: Vendor Insights:
The report highlights some of the prominent market players, who have established themselves as leaders in the global oscillating positive expiratory pressure devices market. Some of the prominent key players in the global OPEP devices market are:
- Smiths Medical, Inc.
- Allergan plc
- Monaghan Medical Corporation & Trudell Medical International
- Others
- PARI GmbH
- WyMedical Pty Ltd
- R. Cegla GmbH & Co. KG
- D-R BURTON HEALTHCARE
- AirPhysio
- Medica Holdings, LLC.
The global oscillating positive expiratory pressure devices market is significantly consolidated, with top two players holding prominent shares in the market revenues. These players are offering oscillating positive expiratory pressure devices under their popular brands such as Portex®, Flutter®, and Aerobika®, among others.
Oscillating Positive Expiratory Pressure (OPEP) Devices Market by Category:
By Product Type:
- Face Mask PEP Devices
- Mouthpiece PEP Devices
- Bottle PEP Devices
By Indication:
- COPD
- Asthma
- Atelectasis
- Bronchitis
- Bronchiectasis
- Cystic Fibrosis
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Personalized Experiences Redefined: Our Customization Report Holds the Answers! https://www.futuremarketinsights.com/customization-available/rep-gb-3397
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube